权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Novel treatment of sleep apnea by upper airway and respiratory muscle training

通过上呼吸道和呼吸肌训练治疗睡眠呼吸暂停的新方法

基本信息

批准号：
10326330
负责人：
Abdulghani Sankari
金额：
--
依托单位：
JOHN D DINGELL VA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-11-01 至 2021-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10326330
关键词：
Acute Address Affect Apnea Cardiovascular system Caring Cervical Cervical spinal cord injury Chronic Clinical Clinical Trials Cognition Continuous Positive Airway Pressure Control Groups Coronary Arteriosclerosis Data Development Device Designs Disease Dropout Drowsiness Educational Intervention Exercise Feasibility Studies General Population Health Heart Diseases High Prevalence Hypertension Impaired cognition Impairment Individual Injury Institutional Review Boards Instruction Integrated Health Care Systems Intervention Knowledge Link Measures Minority Multiple Sclerosis Muscle Myocardial Ischemia Neuromuscular Diseases Oropharyngeal Outcome Patients Personal Satisfaction Phase Pilot Projects Placebos Polysomnography Population Prevalence Provider Quality of life Questionnaires Randomized Reporting Research Resources Respiratory Muscles Respiratory Signs and Symptoms Role Sample Size Severities Sleep Sleep Apnea Syndromes Speech Pathology Spinal cord injury Spinal cord injury patients Spirometry Stroke Structure Symptoms Techniques Teleconferences Testing Therapeutic Thoracic Injuries Tongue Training Training Support United States Veterans Withdrawal acceptability and feasibility adverse outcome airway muscle alternative treatment arm exercise intervention exercise rehabilitation exercise training feasibility testing follow-up improved indexing innovation interest learning materials mechanical device muscle strength novel novel strategies novel therapeutic intervention novel therapeutics poor sleep pressure programs randomized controlled design recruit reduce symptoms respiratory sham-controlled study sleep quality symptomatic improvement tool treatment arm treatment program usability

项目摘要

Project Summary Abstract Title: Novel treatment of sleep apnea by upper airway and respiratory muscle training. In recent years, we and others have discovered that spinal cord injury/disease (SCI/D) is associated with significant increase in the sleep-disordered breathing (SDB) prevalence. Nearly 80% of patients with SCI/D including Veterans suffer from SDB after six months of injury (majority of them 70-80% are obstructive apneas and hypopneas-OSA). However, most patients SCI/D do not tolerate standard SDB treatment (continuous positive airway pressure-CPAP) leading to lack of compliance. Therefore, identifying other therapies is important for this common condition that is linked to poor outcome in the general population (heart disease, stroke, hypertension and poor cognition). It has been reported in sleep apnea able-bodied patients that oropharyngeal muscle exercises for 3 months using speech pathology techniques improve the severity of SDB. Furthermore, previous studies showed respiratory muscle training (RMT) is effective for increasing respiratory muscle strength in people with cervical SCI. However, the effect of combined oropharyngeal and RMT on OSA in patients with SCI is unknown. The purpose of this application is to identify new therapeutic interventions for OSA treatment in Veterans with SCI/D. This application proposes for a pilot study to randomizing 30 Veterans with SCI/D and OSA to receive 3 months of daily (30 minutes) treatment with a validated set of oropharyngeal and RMT (intervention arm) versus sham therapy (control arm). There will be three specific aims to address the following hypotheses: Specific Aim (1): To test recruitment rate and feasibility of a pilot intervention that includes combined oropharyngeal and RMT versus sham treatment in individuals with SCI/D. Specific Aim (2): To test the acceptability and usability of combined oropharyngeal and RMT in individuals with SCI/D. Specific Aim (3): To determine the effect size estimates for clinical endpoints and their associated variability at the end of treatment to calculate an appropriate sample size for an adequately powered clinical trial.

项目摘要标题：通过上气道和呼吸肌治疗睡眠呼吸暂停的新方法训练近年来，我们和其他人发现脊髓损伤/疾病（SCI/D）是一种与睡眠呼吸障碍（SDB）患病率显著增加相关。近80%的SCI/D患者（包括退伍军人）在6个月后患有SDB （其中大多数70-80%是阻塞性呼吸暂停和呼吸不足-OSA）。然而，大多数SCI/D患者不能耐受标准SDB治疗（连续气道正压-CPAP）导致缺乏顺应性。因此，识别其他疗法对于这种与不良结局相关的常见疾病很重要，一般人群（心脏病、中风、高血压和认知能力差）。它有据报道，在睡眠呼吸暂停健全患者中，使用言语病理学技术治疗3个月可改善SDB的严重程度。此外，先前的研究表明，呼吸肌训练（RMT）对增加颈椎脊髓损伤患者的呼吸肌力量。但是，效果联合口咽和RMT对SCI患者OSA的影响尚不清楚。本申请的目的是确定OSA的新治疗干预措施 SCI/D退伍军人的治疗本申请建议进行试点研究，将30名患有SCI/D和OSA的退伍军人随机分组，接受为期3个月的每日（30分钟）经验证的口咽和RMT组（干预组）与假手术组的治疗治疗（对照组）。将有三个具体目标来解决以下问题假设：具体目标（1）：测试招募率和试点干预措施的可行性，包括口咽和RMT联合治疗与假治疗， SCI/D。具体目的（2）：测试口咽和 SCI/D患者的RMT。具体目的（3）：确定临床终点的效应量估计值及其治疗结束时的相关变异性，以计算适当的样本量一个有充分把握的临床试验